Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAAA | Q02083 | 1/20 | 0.57 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.53 |
| ▸ | TSHR | P16473 | 3/20 | 0.52 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.48 |
| ▸ | MAPT | P10636 | 1/20 | 0.48 |
| ▸ | RAD52 | P43351 | 1/20 | 0.48 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.48 |
| ▸ | FAAH | O00519 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
| ▸ | ACHE | P22303 | 3/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12646415 | 1.00 | NAAA (0.57) | NAAAEPHX1TSHRHCAR2MAPT | |
| SCHEMBL12334711 | 1.00 | NAAA (0.57) | NAAAEPHX1TSHRHCAR2MAPT | |
| SCHEMBL4735966 | 1.00 | NAAA (0.57) | NAAAEPHX1TSHRHCAR2MAPT | |
| SCHEMBL1276448 | 1.00 | NAAA (0.57) | NAAAEPHX1TSHRHCAR2MAPT | |
| SCHEMBL22396606 | 1.00 | NAAA (0.57) | NAAAEPHX1TSHRHCAR2MAPT | |
| SCHEMBL22396614 | 1.00 | NAAA (0.57) | NAAAEPHX1TSHRHCAR2MAPT | |
| SCHEMBL1067454 | 1.00 | NAAA (0.57) | NAAAEPHX1TSHRHCAR2MAPT | |
| SCHEMBL9271282 | 1.00 | NAAA (0.57) | NAAAEPHX1TSHRHCAR2MAPT | |
| SCHEMBL17461292 | 1.00 | NAAA (0.57) | NAAAEPHX1TSHRHCAR2MAPT | |
| SCHEMBL12334714 | 1.00 | NAAA (0.57) | NAAAEPHX1TSHRHCAR2MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 380 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260144726-A1 | POLYOL-FREE COSMETIC COMPOSITION COMPRISING ALPHA HYDROXY ACID ESTER | L'OREAL (FR) | 2026-05-28 | — | — | US | claimed |
| US-20250288720-A1 | COATING FOR A BIORESORBABLE SCAFFOLD | SHANGHAI BIORESORBABLE SCAFFOLD TECHNOLOGY CO LTD. (CN) | 2025-09-18 | — | — | US | claimed |
| US-20250041214-A1 | INHALABLE OR INGESTIBLE LACTIC ACID COMPOSITIONS FOR THE TREATMENT OF CHRONIC LUNG DISEASE | ALVEOLUS BIO INC (US) | 2025-02-06 | — | — | US | claimed |
| WO-2024262810-A1 | METHOD FOR PREPARING DOUBLE-LAYER HALIDE PEROVSKITE FILM USING ECO-FRIENDLY SOLVENT, PEROVSKITE FILM PREPARED THEREBY AND ENERGY HARVESTING DEVICE COMPRISING SAME | 한양대학교 산학협력단 | 2024-12-26 | — | — | WO | claimed |
| CN-119013010-A | Inhalable or ingestible lactic acid composition for the treatment of chronic lung disease | 艾维尔勒斯生物公司 | 2024-11-22 | — | — | CN | claimed |
| CN-115078573-B | Method for predicting quality grade of soft white spirit base | 江苏洋河酒厂股份有限公司 | 2024-11-05 | — | — | CN | claimed |
| EP-4447951-A2 | INHALABLE OR INGESTIBLE LACTIC ACID COMPOSITIONS FOR THE TREATMENT OF CHRONIC LUNG DISEASE | Alveolus Bio, Inc. (US) | 2024-10-23 | — | — | EP | claimed |
| CN-114007660-B | Refreshing composition and method for atomizing refreshing composition by using heat-activated microfluidic cartridge | 宝洁公司 | 2024-07-05 | — | — | CN | claimed |
| EP-4356894-A1 | SUSTAINABLE PRODUCT WITH MALODORS | Beiersdorf AG (DE) | 2024-04-24 | — | — | EP | claimed |
| US-11773048-B2 | Process for the preparation of platform chemicals from sugar using acid catalyst | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2023-10-03 | — | — | US | claimed |
| US-20120029228-A1 | CHEMICAL RECYCLING OF PLA BY ALCOHOLYSIS | GALACTIC S.A. (BE) | 2012-02-02 | — | — | US | claimed |
| US-20110207818-A1 | DISINFECTING AND ANTIMICROBIAL COMPOSITIONS | LOPES JOHN ALEX | 2011-08-25 | — | — | US | claimed |
| US-7431088-B2 | Methods of controlled acidization in a wellbore | HALLIBURTON ENERGY SERVICES, INC. (US) | 2008-10-07 | — | — | US | claimed |
| US-20080006175-A1 | Environmental-friendly and solvent-based inkjet ink composition | JETBEST CORPORATION (TW) | 2008-01-10 | — | — | US | claimed |
| US-20070166255-A1 | Treatment of Topical Discomforts Including Acne, Sunburn, Diaper Rash, Wound, Wrinkles and Dandruff/Hair Loss by Natural Lignans via Fatty Acid Desaturase Inhibition | GUPTA SHYAM K | 2007-07-19 | — | — | US | claimed |
| US-7081248-B2 | Concentrated water-dispersible vitamin compositions | ADISSEO FRANCE S.A.S. (FR) | 2006-07-25 | — | — | US | claimed |
| US-20060110415-A1 | Topical Delivery System for Cosmetic and Pharmaceutical Agents | BIODERM RESEARCH (US) | 2006-05-25 | — | — | US | claimed |
| WO-2005049719-A2 | AQUEOUS COMPOSITIONS COMPRISING ESTERS OF LACTIC ACID AND METHODS OF USE | OMNOVA SOLUTIONS INC. (US) | 2005-06-02 | — | — | WO | claimed |
| EP-0793481-B1 | COSMETIC COMPOSITION CONTAINING HYDROXY ALKANOATE DERIVATIVES | UNILEVER PLC (GB) | 2004-06-02 | — | — | EP | claimed |
| EP-0713385-B1 | CLEANSING COMPOSITIONS CONTAINING AN ALKANOATE AS CONDITIONER | UNILEVER PLC (GB) | 1999-03-24 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260144726-A1 | POLYOL-FREE COSMETIC COMPOSITION COMPRISING ALPHA HYDROXY ACID ESTER | HAO2, HADH, LDHA | NAAA 3538/4885EPHX1 2661/4885TSHR 1891/4885 |
| US-20250041214-A1 | INHALABLE OR INGESTIBLE LACTIC ACID COMPOSITIONS FOR THE TREATMENT OF CHRONIC LUNG DISEASE | LCT, LDHA, LDHB | NAAA 1499/4885EPHX1 1870/4885TSHR 4058/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.